HUTCHMED (China) (HCM) Net Equity Issued and Repurchased (2018 - 2021)
HUTCHMED (China) (HCM) posted quarterly Net Equity Issued and Repurchased of $614.9 million for Q2 2021, up 253990.91% quarter-over-quarter from $242000.0 in Q1 2021.
HUTCHMED (China) (HCM) Net Equity Issued and Repurchased (2018 - 2021) Analysis & Trends
HUTCHMED (China) (HCM) has reported Net Equity Issued and Repurchased for 4 consecutive years, with $614.9 million the latest figure, recorded in Q2 2021.
- In Q2 2021, Net Equity Issued and Repurchased changed N/A year-over-year to $614.9 million; the TTM figure through Jun 2021 stood at $614.9 million (up 405.84% YoY), while the FY2025 annual figure was $1.6 million, up 99.75% from the prior year.
- Net Equity Issued and Repurchased grew to $614.9 million in Q2 2021 per HCM's latest filing, from $242000.0 in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $614.9 million in Q2 2021 and bottomed at $24000.0 in Q3 2018.
- Historically, Net Equity Issued and Repurchased has averaged $92.2 million across 4 years, with a median of $360000.0 in 2018.
- Annual changes were most pronounced in 2019 — Net Equity Issued and Repurchased plunged 96.93% — and 2021, when it sank 99.8%.
- HUTCHMED (China)'s Net Equity Issued and Repurchased stood at $3.1 million in 2018, then slumped by 96.93% to $96000.0 in 2019, then surged by 123171.88% to $118.3 million in 2020, then jumped by 419.6% to $614.9 million in 2021.
- Business Quant data shows HCM's Net Equity Issued and Repurchased at $614.9 million in Q2 2021, $242000.0 in Q1 2021, and $118.3 million in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 700,000.00 |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn | 84.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | HUTCHMED (China) | 2.17 Bn | 2.17 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 614.90 Mn |
| Jun 30, 2021 | 614.90 Mn |
| Mar 31, 2021 | 242,000.00 |
| Mar 31, 2021 | 242,000.00 |
| Mar 31, 2020 | 118.34 Mn |
| Mar 31, 2020 | 118.34 Mn |
| Dec 31, 2019 | 96,000.00 |
| Dec 31, 2019 | 96,000.00 |
| Dec 31, 2018 | 3.12 Mn |
| Dec 31, 2018 | 3.12 Mn |
| Sep 30, 2018 | 24,000.00 |
| Sep 30, 2018 | 24,000.00 |
| Jun 30, 2018 | 466,000.00 |
| Jun 30, 2018 | 466,000.00 |
| Mar 31, 2018 | 254,000.00 |
| Mar 31, 2018 | 254,000.00 |